Therapeutics

Small Molecule

Tools

Back to the Top
  • Study completed / Planned end date
  • Planned end date unavailable
  • Study aborted
Small Molecule 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
ALZT-OP1
Phase 3
AZD1446
Phase 2
Acitretin
Phase 2
Atabecestat
Phase 2, Phase 2/3
Avagacestat
Phase 2
Azeliragon
Phase 2/3, Phase 3
BI 409306
Phase 2
Blarcamesine
Phase 2
Brexpiprazole
Phase 3
CHF 5074
Phase 2
CT1812
Phase 1/2, Phase 2
Dexpramipexole
Phase 2
ELND005
Phase 2
EVP-0962
Phase 2
Elenbecestat
Phase 2, Phase 3
Encenicline
Phase 2, Phase 3
FRM-0334
Phase 2
Fosgonimeton
Phase 2
Guanfacine
Phase 3
HMTM
Phase 2, Phase 2/3, Phase 3
Iclepertin
Phase 2
Idalopirdine
Phase 2, Phase 3
Intepirdine
Phase 2, Phase 3
LY3202626
Phase 2
Lanabecestat
Phase 2/3, Phase 3
Levetiracetam
Phase 2
MK-7622
Phase 2
Masitinib
Phase 2, Phase 3
Masupirdine
Phase 2
NIC5-15
Phase 2
Neflamapimod
Phase 2
Nelonicline
Phase 2
ORM-12741
Phase 2
PF-05212377
Phase 2
Pioglitazone
Phase 2, Phase 3
Piromelatine
Phase 2
Relyvrio
Phase 2
Riluzole
Phase 2
Saracatinib
Phase 2
Simufilam
Phase 2
Thalidomide
Phase 2/3
Umibecestat
Phase 2, Phase 2/3
Varoglutamstat
Phase 2
Verubecestat
Phase 1, Phase 2/3, Phase 3